United States · 
Who invested in Biosynthetic Technologies?
Biosynthetic Technologies's investors include Evonik Venture Capital.
United States · Venture startup
Who invested in Biosynthetic Technologies
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2014, from 1 source
- Latest round
- VentureJul 2014
- Investors
- 1
The rounds
- Jul 2014VentureAmount undisclosed
From a historical funding recordSEC filing: $12M sold, first sale May 2014
Founders and team
From Biosynthetic Technologies's own website and the SEC filings it signed: 7 on the team.
- Dr. Matt KriechCEO
- Brett SharpCFO
- Chris CrawfordChief Commercial Officer
- Jeremy ForestChief Ip Counsel
- Alex KitchelDirector Of Operations
- Brian McCluskeySenior Account Manager
- Allen BarbieriExecutive Officer, Directori
On the board, as filediBernhard MohrGerald KohlenbergerJohn HopkinsKent WassonMeghan SharpSteve Bierschenk
Also claim to have backed them
These 2 firms list Biosynthetic Technologies as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Biosynthetic Technologies
How much has Biosynthetic Technologies raised?
Biosynthetic Technologies has raised 1 round since 2014, none with a disclosed amount.
When did Biosynthetic Technologies last raise?
Biosynthetic Technologies's most recent round was a Venture in Jul 2014.
Who backed Biosynthetic Technologies first?
Biosynthetic Technologies's first round on record, in Jul 2014, was backed by Evonik Venture Capital.
What stage is Biosynthetic Technologies at?
Biosynthetic Technologies's latest named round is a Venture, in Jul 2014.
Where is Biosynthetic Technologies based?
Biosynthetic Technologies is based in the United States.
Companies like Biosynthetic Technologies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.